ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

VSTM2A reverses immunosuppression in colorectal cancer by antagonizing the PD-L1/PD-1 interaction.

Yujuan Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.